| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Servicio de Endocrinología (R.A., F.S.-F.), Hospital Carlos III-C.I.C., Instituto de Salud Carlos III, Madrid 28029, Spain; and Servicio de Endocrinología (L.C., C.N.), Hospital Ramón y Cajal, Madrid 28034, Spain
Address all correspondence and requests for reprints to: Dr. Franco Sánchez-Franco, Hospital Carlos III. C/Sinesio Delgado, 10-12, Madrid 28029. E-mail: fsanchez{at}hciii.insalud.es.
To define the role of GH during central nervous system development, we performed studies in cultured rat cerebral cortical cells from 14- (E14) and 17-d-old embryos (E17). The expression of GH receptor, IGF-I receptor, and IGF-I mRNAs was confirmed. In E17, GH increased total cell number (3.9-fold), [3H]-thymidine incorporation (3.5-fold), proliferating cell nuclear antigen levels (2.5-fold), and bromodeoxyuridine (BrdU)-positive cells (2.5-fold). GH action on nestin/BrdUpositive cells was increased in E14 cells at 3 d in vitro (80-fold) but not at 7 d in vitro. In E14 cells, GH increased (9.5-fold) ß-tubulin/BrdU cells. In E17 cells, GH induced neuronal differentiation, as indicated by the absence of ß-tubulin/BrdU-positive cells and the 5.9-fold increment of ß-tubulin protein, and increased glial fibrillary acidic protein/BrdU-positive cells (2.5-fold) and glial fibrillary acidic protein expression (4.5-fold). GH-induced proliferation and differentiation was blocked by IGF-I antiserum. GH increased IGF-binding protein-3 (IGFBP-3), IGF-I receptor protein and its phosphorylation. This study shows that GH promotes proliferation of neural precursors, neurogenesis, and gliogenesis during brain development. These responses are mediated by locally produced IGF-I. GH-induced IGFBP-3 may also have a role in these responses. Therefore, GH is able to activate the IGF-I/IGFBP-3 system in these cerebral cells and induce a physiological action of IGF-I.
This article has been cited by other articles:
![]() |
A.-L. Svensson, N. Bucht, M. Hallberg, and F. Nyberg From the Cover: Reversal of opiate-induced apoptosis by human recombinant growth hormone in murine foetus primary hippocampal neuronal cell cultures PNAS, May 20, 2008; 105(20): 7304 - 7308. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain Endocr. Rev., December 1, 2005; 26(7): 916 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fleenor, J. Oden, P. A. Kelly, S. Mohan, S. Alliouachene, M. Pende, S. Wentz, J. Kerr, and M. Freemark Roles of the Lactogens and Somatogens in Perinatal and Postnatal Metabolism and Growth: Studies of a Novel Mouse Model Combining Lactogen Resistance and Growth Hormone Deficiency Endocrinology, January 1, 2005; 146(1): 103 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Russo, S. Metaxas, K. Kobayashi, M. Harris, and G. A. Werther Antiapoptotic Effects of Leptin in Human Neuroblastoma Cells Endocrinology, September 1, 2004; 145(9): 4103 - 4112. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Sanders, M. A. Walter, E. Parker, C. Aramburo, and S. Harvey Opticin Binds Retinal Growth Hormone in the Embryonic Vitreous Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5404 - 5409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Baudet, E. J. Sanders, and S. Harvey Retinal Growth Hormone in the Chick Embryo Endocrinology, December 1, 2003; 144(12): 5459 - 5468. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |